Zobrazeno 1 - 10
of 202
pro vyhledávání: '"V, Schwoebel"'
Autor:
Kirchhoff
Publikováno v:
Geographische Zeitschrift, 1905 Jan 01. 11(9), 537-538.
Externí odkaz:
https://www.jstor.org/stable/27805359
Publikováno v:
The Biblical World, 1915 Mar 01. 45(3), 183-183.
Externí odkaz:
https://www.jstor.org/stable/3142546
Publikováno v:
The Biblical World, 1914 Oct 01. 44(4), 293-293.
Externí odkaz:
https://www.jstor.org/stable/3142464
Autor:
V Schwoebel
Publikováno v:
Indian Journal of Tuberculosis. 67:S33-S42
Surveillance of tuberculosis is one of the oldest disease surveillance systems in the world. This article briefly reviews its history, describes its methods and main results, with a specific focus on low- and middle-income countries, and underlines i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d83dfb764d94a801d2eb346beca898d2
https://doi.org/10.1016/j.ijtb.2020.11.006
https://doi.org/10.1016/j.ijtb.2020.11.006
Autor:
E Masserey, Anne Detjen, M Adjobimey, A G Wandji, Stephen M. Graham, C Delacourt, S Gnanou, Arnaud Trébucq, P Mselatti, K G Koura, Alberto Roggi, J-C Gody, V Schwoebel
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 24:452-460
SETTING: The largest cities in Benin, Burkina Faso, Cameroon and Central African Republic.OBJECTIVE: To demonstrate the feasibility and document the effectiveness of household contact investigation and preventive therapy in resource-limited settings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a5e81e409999f1fffe263d44aec79b
https://doi.org/10.5588/ijtld.19.0712
https://doi.org/10.5588/ijtld.19.0712
Autor:
P. Gueudet, D. Diulius, A. Beaumont, H. Aumaître, Harold Noel, M. Ledrans, M. Médus, C. Durand, V. Schwoebel, L. Colombain
Publikováno v:
Infectious Diseases Now
Europe PubMed Central
Europe PubMed Central
Introduction La pandémie de Covid-19 est apparue comme un révélateur des inégalités sociales de santé. En mars 2020, de nombreux cas ont été déclarés dans trois quartiers défavorisés où vit une importante communauté gitane. Une étude d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab47230b7d9f484d50ccde0c2535e77
https://doi.org/10.1016/j.idnow.2021.06.010
https://doi.org/10.1016/j.idnow.2021.06.010
Autor:
Lutgarde Lynen, Nimer Ortuno-Gutierrez, Bouke C. de Jong, Alberto Roggi, Mourtala Mohamed Assao-Neino, Tom Decroo, Alphazazi Soumana, Mahamadou Bassirou Souleymane, Saidou Mamadou, Assiatou Gagara-Issoufou, Souleymane Hassane-Harouna, Ibrahim Mamane Lawan, Armand Van Deun, V Schwoebel, Zelika Hamidou-Harouna, Alberto Piubello
Publikováno v:
The European respiratory journal. 57(1)
The short treatment regimen (STR) achieves a >80% cure in rifampicin-resistant tuberculosis (RR-TB) patients. However, ototoxicity induced by the injectable is a concern. This is the first study to evaluate the replacement of injectables by linezolid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea99bf523e3be1ea191c077683bbc58
https://pubmed.ncbi.nlm.nih.gov/32703777
https://pubmed.ncbi.nlm.nih.gov/32703777
Autor:
K G Koura, V Schwoebel, Armand Van Deun, Tom Decroo, Arnaud Trébucq, Alberto Piubello, Chen Yuan Chiang
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1, p 55 (2019)
Journal of Clinical Medicine, Vol 9, Iss 1, p 55 (2019)
About ten years ago, the first results of the so-called “Bangladesh regimen”, a short regimen lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (MDR-TB) treatment. Similar short regimens were studied in dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f05db973f727c09835360091cd16b65
https://pubmed.ncbi.nlm.nih.gov/31881691
https://pubmed.ncbi.nlm.nih.gov/31881691
Autor:
Arnaud Trébucq, Alberto Piubello, V Schwoebel, Bouke C. de Jong, Hans L. Rieder, Armand Van Deun, Tom Decroo, Chen Yuan Chiang, Sabira Tahseen, Nimer Ortuno-Gutierrez
Publikováno v:
International journal of antimicrobial agents. 55(1)
The 2018 World Health Organization (WHO) treatment guidelines for multidrug-/rifampicin-resistant tuberculosis (MDR/RR-TB) give preference to all-oral long regimens lasting for 18-20 months. The guidelines strongly recommend combining bedaquiline, le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd224e714b1f1d7edd80ae80214bbd16
https://pubmed.ncbi.nlm.nih.gov/31626907
https://pubmed.ncbi.nlm.nih.gov/31626907
Autor:
V Schwoebel, K G Koura, E Heldal, A. Van Deun, C. Y. Chiang, Arnaud Trébucq, Alberto Piubello, Hans L. Rieder, Nadia Aït-Khaled
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 23(5)
sec id="st1"titleOBJECTIVE/titleTo assess whether the revised 2013 World Health Organization (WHO) definitions for multidrug-resistant tuberculosis (MDR-TB) treatment outcomes apply to shorter treatment regimens in low- and middle-income countries an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fe558785ab1448cf570ca3db388d87
https://pubmed.ncbi.nlm.nih.gov/31439124
https://pubmed.ncbi.nlm.nih.gov/31439124